Community Shares | July 1st 2024
This week’s articles: A new study has investigated factors influencing the age at which mothers first became concerned about their child’s development and the subsequent time it took to start services for children with autism; A systematic review has recently evaluated the association between cannabis use during pregnancy and the risk of long-term neuropsychiatric issues in offspring; The American Institutes for Research’s Center for the Analysis of Longitudinal Data in Education Research (CALDER) has just released an analysis revealing that approximately 8,500 fewer K-5 students in Washington state were identified for special education services during the pandemic, representing a 20-23% drop from typical rates; Documenting Hope is presenting a unique dual-conference event at the upscale Omni ChampionsGate in Orlando, Florida, from November 15-17, 2024.
CBD and Metformin Found to Alleviate Behavioral Issues in Autism-Linked Syndromes
Recent research presented at the Federation of European Neuroscience Societies (FENS) Forum 2024 has found that cannabidiol (CBD) and metformin can alleviate behavioral difficulties in mouse models of Fragile X and Phelan-McDermid syndromes, both of which are linked to autism spectrum disorder (ASD).
Marijuana Use During Pregnancy Linked to Autism
A new Canadian study which examined 500,000 births in Ontario between 2007 and 2012 found that .6% of pregnant mothers used Cannabis while pregnant. Of the total birth cohort of 500,000, 1.4% of children later received an autism diagnosis. That number increased to 2.2% for children whose mothers used marijuana during pregnancy. Public health institutions in Canada and the United States have long warned pregnant women to abstain from Cannabis while pregnant.
